European Headache Federation guideline on the use of calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) for migraine prevention
Anti-CGRPs, from Molecule to Man
This meeting was held in Copenhagen, 29-30 november 2019
Brief summary from the migraine symposium
TEVA Nordics has since 2013 arranged an annual scientific symposium within multiple sclerosis intended to be complementary to other international congresses and with highest clinical and scientific relevance.
The topics and speakers have been selected by a Steering Committee consisting of leading migraine experts from each Nordic country.
If you have any questions regarding this symposium, please contact your local Teva medical representative in Sweden: Fredrik Blomstrand / email@example.com